Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004561466 | SCV005049206 | uncertain significance | Dyskeratosis congenita | 2023-12-02 | criteria provided, single submitter | clinical testing | The p.L103V variant (also known as c.307C>G), located in coding exon 2 of the TERT gene, results from a C to G substitution at nucleotide position 307. The leucine at codon 103 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |